Product NDC: | 55111-250 |
Proprietary Name: | Terbinafine Hydrochloride |
Non Proprietary Name: | Terbinafine Hydrochloride |
Active Ingredient(s): | 250 mg/1 & nbsp; Terbinafine Hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55111-250 |
Labeler Name: | Dr.Reddys Laboratories Limited |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA076390 |
Marketing Category: | ANDA |
Start Marketing Date: | 20070702 |
Package NDC: | 55111-250-30 |
Package Description: | 30 TABLET in 1 BOTTLE (55111-250-30) |
NDC Code | 55111-250-30 |
Proprietary Name | Terbinafine Hydrochloride |
Package Description | 30 TABLET in 1 BOTTLE (55111-250-30) |
Product NDC | 55111-250 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Terbinafine Hydrochloride |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20070702 |
Marketing Category Name | ANDA |
Labeler Name | Dr.Reddys Laboratories Limited |
Substance Name | TERBINAFINE HYDROCHLORIDE |
Strength Number | 250 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Allylamine [Chemical/Ingredient],Allylamine Antifungal [EPC] |